Trial Profile
A Phase I Trial of WEE1 Inhibition With Chemotherapy and Radiotherapy as Adjuvant Treatment, and a Window of Opportunity Trial With Cisplatin in Patients With Head and Neck Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Mar 2024
Price :
$35
*
At a glance
- Drugs Adavosertib (Primary) ; Cisplatin
- Indications Head and neck cancer; Hypopharyngeal cancer; Laryngeal cancer; Mouth neoplasm; Squamous cell cancer
- Focus Adverse reactions
- Acronyms WISTERIA
- 15 Mar 2021 Status changed from active, no longer recruiting to completed.
- 25 Nov 2020 Planned End Date changed from 1 Jul 2020 to 29 Jan 2021.
- 07 Dec 2019 Planned End Date changed from 1 Dec 2019 to 1 Jul 2020.